Pathological protein deposits linked to Alzheimer’s disease and cerebral amyloid angiopathy can be triggered not only by the administration of pathogenic misfolded protein fragments directly into the brain but also by peripheral…
Category: News
Research suggests lowering cholesterol can reduce benign prostatic hyperplasia
A cholesterol-lowering drug reduced the enlarged prostates of hamsters to the same extent as a drug commonly used to treat benign prostatic hyperplasia (BPH), report researchers at Children’s Hospital Boston and their…
Parent-only treatments for childhood obesity work effectively
A study led by a researcher at the University of California, San Diego School of Medicine indicates that parent-only treatments for childhood obesity work equally as well as plans that include parents…
TOBI reduces mortality in patients with cystic fibrosis, Pa lung infection
A new analysis of data from more than 12,000 people with cystic fibrosis (CF) and Pseudomonas aeruginosa (Pa) lung infection in the Cystic Fibrosis Foundation’s Patient Registry shows that use of TOBI®…
apoA-V may reduce high triglyceride levels, coronary artery disease
An exciting new study conducted by Children’s Hospital Oakland Research Institute (CHORI) scientists identified that an injection of the protein apolipoprotein (apo)A-V may reduce high triglyceride levels in the blood and subsequently…
Neoprobe submits BLA response letter to FDA to commercialize RIGS technology
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has submitted a response letter to the U.S. Food and Drug Administration (FDA) regarding…
Daiichi Sankyo launches Inavir inhalation powder for influenza in Japan
Hovione has been advised by Daiichi Sankyo Company Ltd that Inavir(R) has been launched in Japan. Inavir(R) is an inhalation powder which is delivered by the TwinCaps(R) inhaler to treat influenza. TwinCaps(R)…
ACOG joins Jay Monahan Center to develop new chapter on Female Cancers resource guide
The New York State Chapter of the American Congress of Obstetricians and Gynecologists, District II (ACOG) has partnered with the Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian Hospital/Weill Cornell Medical Center…
Biomarkers can improve ability to identify patients at high risk of CKD
Measuring three biomarkers in a single blood sample may improve physicians’ ability to identify patients at high risk of developing chronic kidney disease (CKD), according to a study appearing in an upcoming…
Malaria deaths in India 13 times higher than who estimate, study says
“Malaria kills around 205,000 people in India each year, more than 13 times the estimate made by the World Health Organization, researchers said on Thursday,” Reuters reports (Ee Lyn, 10/20). The WHO…
Clinical research scholar receives grant to promote lifestyle changes for HIV patients
Between the demands of work, family and friends, many women find health takes a back seat. Women with HIV are no exception. “Many women with the HIV face challenges from sleepless nights…
Idera announces IMO-3100 Phase 1 clinical trial results for autoimmune disease
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and…
Medtronic’s Xpander II receives FDA clearance for vertebral compression fractures
Medtronic Inc. (NYSE:MDT) today announced Food and Drug Administration (FDA) clearance of the Kyphon Xpander II Inflatable Bone Tamp (IBT) for the treatment of vertebral compression fractures with minimally invasive Kyphon® Balloon…
Researchers determine 3D structure of complete egg receptor molecule that binds sperm
Researchers at the Swedish medical university Karolinska Institutet have been able to describe the 3D structure of a complete egg receptor that binds sperm at the beginning of fertilization. The results, published…
Orthopaedic Surgeon implants first MIDLINE device at Valley Hospital
Just days after Centinel Spine’s new STALIF MIDLINE™ Integrated Interbody Fusion™ system was unveiled at the annual meeting of the North American Spine Society (NASS), the first MIDLINE device has been successfully…